. Author manuscript; available in PMC: 2021 Oct 1.

Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2019 Jul 29;59(10):1146–1155. doi: 10.1016/j.jaac.2019.06.013

Table 6.

Clinical predictors at intake of lithium exposure (Lithium=23, Other Mood Stabilizer=143), adjusting for demographic predictors in Table 1 (i.e. assessment date, age of bipolar onset)^a

Variable	OR (Cl)	P
Suicidal ideation	3.2(1.1, 9.1)	.03
Suicide attempts	2.1 (0.2, 21.6)	.53
Threshold Depression	1.2 (0.5, 3.0)	.70
Threshold (Hypo)mania	1.8 (0.7, 4.7)	.20
PSF_worst	1.1 (0.9, 1.3)	.37
Aggression (BCS)	1.0 (0.9, 1.1)	.70
Bipolar Type (BD 1 vs BD NOS)	1.2 (0.5, 3.1)	.65
Lifetime hospitalizations	0.8 (0.5, 1.2)	.26
Lifetime DBD	0.5 (0.2, 1.5)	.22
Lifetime Anxiety	2.2 (0.8, 5.9)	.12
Lifetime Psychosis	0.9 (0.3, 2.8)	.83
Antidepressant (during 1^st f/u period)	1.4 (0.5, 3.9)	.47
Stimulant (during 1^st f/u period)	1.0 (0.4, 2.1)	.96

Note:

Substance abuse could not be assessed due to low frequency of this predictor at baseline (n=11); BCS=Behavior Control Scale; BD=Bipolar Disorder; BD NOS=Bipolar Disorder, Not Otherwise Specified; PSF=Psychosocial Functioning.